The approval was based on a cohort of treatment-naïve patients in the Beamion LUNG-1 trial who had unresectable or metastatic, non-squamous NSCLC with HER2 tyrosine kinase domain mutations.

The Food and Drug Administration (FDA) has granted Priority Review to the supplemental New Drug Application (sNDA) for olezarsen in the treatment of severe hypertriglyceridemia.

Results from ADAPT OCULUS are expected to support a sBLA submission to the FDA to secure a label expansion for oMG.

Clinicians now have an FDA-approved liquid desmopressin option for central diabetes insipidus, designed for dosing consistency across the age spectrum.

HealthDay News — COVID-19 vaccination, especially with a booster dose, is associated with reduced odds of preeclampsia (PE), according to a study published online February 18 in eClinicalMedicine.

Findings based on comparison to glycopyrrolate-formoterol and tiotropium-olodaterol in patients newly prescribed LAMA-LABA inhalers.

Novo Nordisk announced Tuesday that it will cut US list prices of Ozempic and Wegovy by up to 50% starting next year. The ...